Isolated limb infusion for local control of lower limb melanoma: radiologic aspects.

To describe the technical radiological aspects of isolated limb infusion (ILI) to assist those procedural radiologists who carry out ILI on an occasional only basis and to inform the Australian radiologist community about this deserving but relatively little known radiological procedure. Retrospective audit of radiological catheter placement for 23 lower limb ILI procedures carried out for 16 patients with locally recurrent melanoma over 2 years (January 2002 to December 2003). Arterial and venous catheter placement, although sometimes difficult, was successful in all but four occasions. Unfavourable vascular anatomy was the main reason for failure. If approached systematically and with the knowledge of the patient's vascular anatomy, the outcome will be satisfactory in the hands of the generalist. Knowing the common technical pitfalls will certainly assist. Isolated limb infusion deserves to be more widely known in the radiological and surgical communities.

[1]  P. Kam,et al.  Prognostic factors after isolated limb infusion with cytotoxic agents for melanoma , 2002, Annals of Surgical Oncology.

[2]  P. Würl,et al.  Technique and results of regional hyperthermic cytostatic arm perfusion for malignant melanoma , 1997, Surgery Today.

[3]  F. van Coevorden,et al.  Isolated limb perfusion with tumor necrosis factor‐α and melphalan for patients with unresectable soft tissue sarcoma of the extremities , 2003, Cancer.

[4]  M. Lens,et al.  Isolated limb perfusion with melphalan in the treatment of malignant melanoma of the extremities: a systematic review of randomised controlled trials. , 2003, The Lancet. Oncology.

[5]  A. Eggermont,et al.  The role of isolated limb perfusion for melanoma confined to the extremities. , 2003, The Surgical clinics of North America.

[6]  J. Wilt,et al.  Isolated Limb Perfusion in the Management of Patients With Recurrent Limb Melanoma: An Important but Limited Role , 2001, Annals of Surgical Oncology.

[7]  A. Eggermont,et al.  Isolated limb perfusion for extremity soft-tissue sarcomas, in-transit metastases, and other unresectable tumors: Credits, debits, and future perspectives , 2001, Current oncology reports.

[8]  M. Henderson,et al.  Isolated limb infusion for melanoma: a simple alternative to isolated limb perfusion. , 2001, Canadian journal of surgery. Journal canadien de chirurgie.

[9]  R. Tominaga,et al.  Current Techniques of Hyperthermic Isolated Limb Perfusion for Malignant Melanoma , 2000, Surgery Today.

[10]  A. Eggermont,et al.  Hyperthermic isolated limb perfusion with tumor necrosis factor alpha, interferon gamma, and melphalan for locally advanced nonmelanoma skin tumors of the extremities: a multicenter study. , 1999, Archives of surgery.

[11]  P. Kam,et al.  Isolated limb infusion with cytotoxic agents: a simple alternative to isolated limb perfusion. , 1998, Seminars in surgical oncology.

[12]  R. MacKie,et al.  A single centre's 10 year experience with isolated limb perfusion in the treatment of recurrent malignant melanoma of the limb. , 1996, European journal of cancer.

[13]  I. Eisenbarth,et al.  Investigations of neurofibromin expression in the skin of patients with NF 1 (neurofibromatosis type 1) , 1994 .

[14]  E. Krementz,et al.  Chemotherapy by regional perfusion for limb melanoma. , 1987, The American surgeon.